Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burman

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
The Journal of Clinical Investigation|October 15, 2005
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogsEdward S Morris, Kelli P A MacDonald, Vanessa Rowe, et al.
Blood|April 17, 2009
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationRachel D Kuns, Edward S Morris, Kelli P A Macdonald, et al.
Blood|October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVLKate A Markey, Angela C Burman, Tatjana Banovic, et al.
Journal of Medicinal Chemistry|March 22, 2007
Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agentsMukund K Gurjar, Radhika D Wakharkar, Anu T Singh, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
The Journal of Clinical Investigation|October 15, 2005
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogsEdward S Morris, Kelli P A MacDonald, Vanessa Rowe, et al.
Blood|April 17, 2009
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationRachel D Kuns, Edward S Morris, Kelli P A Macdonald, et al.
Blood|October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVLKate A Markey, Angela C Burman, Tatjana Banovic, et al.
Journal of Medicinal Chemistry|March 22, 2007
Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agentsMukund K Gurjar, Radhika D Wakharkar, Anu T Singh, et al.
Pageof 7